The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback

Tuğtepe, Halil; Thomas, David Terence; Ergün, Raziye; Kalyoncu, Aybegüm; Kaynak, Ayten; Kastarli, Cansu; Dağlı, Tolga E.

doi:10.1016/j.jpurol.2014.10.016

Cited by 31 publications

(28 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…64,65 Two sham-controlled studies showed similar results, 66,67 as has a 2015 uncontrolled study reporting complete and partial response rates of 70 and 22%, respectively. 68 Recently, two groups compared TENS to approved treatment options for OAB in children. Sillén et al found no significant differences in a randomized trial comparing urotherapy alone to urotherapy and TENS.…”

Section: Neuromodulationmentioning

confidence: 99%

Overactive bladder in children

Ramsay¹,

Bolduc²

2017

CUAJ

View full text Add to dashboard Cite

Overactive bladder (OAB) is a highly prevalent disorder in the pediatric population. This condition is especially troublesome for pediatric patients and their families when associated with incontinence, since it negatively affects self-esteem and impairs children's development. From the patient's perspective, urgency and urge incontinence can have a significant impact, negatively affecting their quality of life. For a therapy to have true benefit, changes must not only be statistically significant, but must also be perceived as meaningful by the patient. A stepwise approach is favoured to treat this pathology, starting with behavioural therapy, followed by medical management, and eventually more invasive procedures.Antimuscarinic agents are the mainstay of medical treatment for OAB. Oxybutynin is the most commonly used antimuscarinic in the pediatric population. However, some patients have a suboptimal response to antimuscarinics and many experience bothersome side effects, which have been documented with all antimuscarinics to a significantly higher degree than placebo. Although there have been reports about the use of tolterodine, fesoterodine, trospium, propiverine, and solifenacin in children, to date, only oxybutynin has been officially approved for pediatric use by medical authorities in North America. This review will address alternative treatment options for pediatric patients presenting with OAB, from conservative measures to more invasive therapies.

show abstract

Section: Neuromodulationmentioning

confidence: 99%

Overactive bladder in children

Ramsay¹,

Bolduc²

2017

CUAJ

View full text Add to dashboard Cite

show abstract

“…By evaluating the results of pelvic floor muscles EMG prior to and following the BF therapy, 14 out of 18 participants gained significant improvement. Authors have described a significant improvement in UTIs, urge incontinence, fractionated voiding, constipation, voided volume, maximum flow rate, average flow rate as well as postvoid residue in both patients with DV and OAB, but better results are observed in patients with DV [18].…”

Section: Discussionmentioning

confidence: 99%

Biofeedback in the treatment of lower urinary tract symptoms in children

Djermanov

Zivkovic

2018

Med pregl

View full text Add to dashboard Cite

Introduction. Bladder and bowel dysfunction describes a large spectrum of lower urinary tract symptoms along with fecal elimination issues. The aim of the study was to analyze the effects of biofeedback treatment in children with lower urinary tract symptoms. Material and Methods. A prospective study analyzed the effects of biofeedback treatment conducted in children with lower urinary tract symptoms. Questionnaires and voiding diaries were collected prior to the treatment. The patients were followed for two weeks on daily basis. After the completion of the treatment, the data from voiding diaries and questionnaires were analyzed. Results. A total of 18 children were referred for biofeedback treatment. Seven patients had an overactive bladder. seven had isolated dysfunctional voiding, and in the third group three had difficulties starting to void and one had daily incontinence with dysfunctional voiding. A total of 14 patients presented with improvement of symptoms. The analyzed data showed no measurable improvement in one patient, even though he reported a personal feeling of improvement. Three patients without positive effects of the therapy were immature and non-cooperative. In six out of seven patients with overactive bladder with urine leakage, the symptom disappeared by the end of the treatment. Conclusion. Biofeedback is a very useful tool in the treatment of lower urinary tract symptoms in pediatric population. Although the main indication for initiating this therapy is dysfunctional voiding, the study showed an improvement of symptoms in patients with overactive bladder as well.

show abstract

“…In a study of PMNE patients undergoing TCPSE, complete response was reported in 43% and partial response in 21% ( 48 ). In a study of patients who were refractory to initial medical treatment or biofeedback, the response rate of TENS was found to be 70.4% after 3 months of treatment ( 49 ).…”

Section: Approach To Treatment Of a Child With Nocturnal Enuresismentioning

confidence: 99%

Primary Nocturnal Enuresis: A Review

Arda¹,

Çakıroğlu²,

Thomas

2016

Nephrourol Mon

View full text Add to dashboard Cite

ContextNocturnal enuresis or bedwetting is the most common type of urinary incontinence in children. It has significant psychological effects on both the child and the family. Enuresis nocturna is defined as the inability to hold urine during the night in children who have completed toilet training. It is termed as being “primary” if no continence has ever been achieved or “secondary if it follows at least 6 months of dry nights. The aim of this review was to assemble the pathophysiological background and general information about nocturnal enuresis.Evidence AcquisitionThis review was performed by evaluating the literature on nocturnal enuresis published between 1970 and 2015, available via PubMed and using the keywords “nocturnal enuresis,” “incontinence,” “pediatric,” “review,” and “treatment.”ResultsChildren with nocturnal enuresis produce urine at higher rates during the night, and may have lower bladder capacities. Some children with nocturnal enuresis may also have daytime urgency, frequency, and urinary incontinence. Treatment includes aggressive treatment of accompanying constipation or urinary tract infections, behavioral changes, and medical therapy. Alarm therapy remains the first-line treatment modality for primary nocturnal enuresis. High rates of patient compliance and relapse mean that alternative treatments remain on the agenda.ConclusionsNocturnal enuresis is a common problem that has multifaceted effects on both the child and the family. Due to multiple etiologic factors, nocturnal enuresis is still not clearly defined.

show abstract

The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback

Cited by 31 publications

References 19 publications

Overactive bladder in children

Overactive bladder in children

Biofeedback in the treatment of lower urinary tract symptoms in children

Primary Nocturnal Enuresis: A Review

Contact Info

Product

Resources

About